The Drug Repurposing Hub - Resources for Drug Repurposing

Join us as we welcome Dr. Steven Corsello, MD, Founder of the Drug Repurposing Hub at the Broad Institute, Cambridge. In this session, Dr. Corsello will discuss the Drug Repruposing Hub, an open-access repository of more than 6000 compounds, many of which have been FDA approved, and his experience strategizing candidates for drug repurposing for cancer therapeutics.

Tuesday, November 17, 2020

12:00 pm - 1:00 pm

Zoom Webinar - registrants will receive the Zoom link closer to the event date.

Dr. Steven Corsello, MD, Founder, Drug Repurposing Hub

Dr. Corsello is the founder of the Drug Repurposing Hub at the Broad Institute and an attending physician at the Dana-Farber Cancer Institute. He currently leads an effort to evaluate all available clinical drugs using information-rich cellular assays and to develop new cancer treatments. As a key contributor to the Connectivity Map Project, he also develops translational applications for perturbational gene expression profiling.

Dr. Corsello holds an A.B. in biochemical sciences from Harvard College and an MD from Harvard Medical School, where he developed gene expression-based screening approaches for leukemia. He completed residency training in internal medicine at Massachusetts General Hospital and a combined fellowship program in hematology and medical oncology at the Dana-Farber-Cancer Institute.